Initial clinical data from the ongoing Phase 1 study of ACR-2316, a potential first- and best-in-class WEE1/PKMYT1 inhibitor, including safety data, dosing regimen, and early clinical activity across ...
CTA President Kinsey Fabrizio discusses the shift toward agentic AI, household robotics, and the future of quantum technology ...
1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS (TM), a multimodal AI model that achieves state-of-the-art ...
It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. -- Surrogate assays are a breakthrough for AI model training. 1910 ...
PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...
Artificial intelligence is revolutionizing antibiotic discovery, potentially tackling antibiotic-resistant bacteria and ...
Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...
Robots displayed at CES 2026 show they're not trying to be sci-fi anymore. They’re practical, folding laundry and offering ...
Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...
1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS™, a multimodal AI model that achieves state-of-the-art accuracy ...
Under the terms of the agreement, Iktos will leverage its AI-driven generative design platform to accelerate the discovery of optimized small-molecule candidates against an undisclosed oncology target ...
The E-Summit will showcase numerous innovative startups at its Startup Expo, while also organizing Youth Entrepreneurship Challenge (YEC) finale, giving school students the opportunity to pitch their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback